portfolio as of Q2 2026, filed Aug 14, 2026
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
5 of 19 holdings are Undervalued or On Sale by our valuation (26% of the money).
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 5 not valued.
Bill & Melinda Gates Foundation Trust's portfolio holds 24 stocks worth $34.4B at the end of Q2 2026. The largest positions are BRK-B, CAT, CNI, WM and DE.
In Q2 2026, Bill & Melinda Gates Foundation Trust opened 2 new positions (FDXF and HD).
In Q2 2026, Bill & Melinda Gates Foundation Trust trimmed BRK-B.
BRK-B, FDX, KOF, KHC and HRL are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 14, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →